Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD

Bone Marrow Transplantation

Volumn 45, Issue 4, 2010, Pages 730-737

  Pinomaki A ^a   Volin, L ^a   Joutsi Korhonen, L ^a   Virtanen, J O ^b   Lemponen, M ^a   Ruutu, T ^a   Lassila, R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Coagulation; Fibrinolysis; GVHD; SCT; Thrombin

Indexed keywords

CYCLOPHOSPHAMIDE; D DIMER; METHOTREXATE; METHYLPREDNISOLONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; ENGRAFTMENT; ENZYME ACTIVITY; FEMALE; FIBRINOLYSIS; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; TURNOVER TIME; UPREGULATION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; FEMALE; FIBRINOLYSIS; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSPLANTATION, ISOGENEIC; YOUNG ADULT;

EID: 77950614446     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.227     Document Type: Article

References (29)

1. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495-504.
2. Van der Plas RM, Schiphorst ME, Huizinga EG, Hené RJ, Verdonck LF, Sixma JJ et al. Von Willebrand Factor Proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 1999; 93: 3798-3802.
3. Ruutu T, Barosi G, Benjamin RJ, Benjamin RJ, Clark RE, George JN et al. European Group for Blood and Marrow transplantation; European LeukemiaNet. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007; 92: 95-100.
4. Carreras E. Veno-occlusive disease of the liver after hemopoietic cell transplantation. Eur J Haematol 2000; 64: 281-291.
5. Cahill RA, Spitzer TR, Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996; 18: 177-184.
6. Testa S, Manna A, Porcellini A, Maffi F, Morstabilini G, Denti N et al. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. Bone Marrow Transplant 1996; 18: 383-388.
7. Biedermann BC. Vascular endothelium and graft-versus-host disease. Best Pract Res Clin Haematol 2008; 21: 129-138.
8. Holler E, Kolb HJ, Mö ller A, Kempeni J, Liesenfeld S, Pechumer H et al. Increased serum levels of tumor necrosis factor a precede major complications of bone marrow transplantation. Blood 1990; 75: 1011-1016.
9. Woywodt A, Scheer J, Hambach L, Buchholz S, Ganser A, Haller H et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 3603-3605. (Pubitemid 38525700)
10. Aird WC. Endothelial-platelet interplay in sepsis. Hematol Am Soc Hematol Educ Program 2003, 497-503.
11. Pihusch R, Wegner H, Salat C, Pihusch M, Holler E, Kolb HJ et al. Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 30: 381-387. (Pubitemid 35203511)
12. Nürnberger W, Michelmann I, Burdach S, Gö bel U. Endothelial dysfunction after bone marrow transplantation: Increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol 1998; 76: 61-65.
13. Brown SA, Davies SV, Fegan C, West R, Giddings J, Whittaker J et al. Haemostatic and fibrinolytic responses to bone marrow transplantation. Br J Haematol 1999; 104: 468-474.
14. Catani L, Gugliotta L, Mattioli Belmonte M, Vianelli N, Gherlinzoni F, Miggiano MC et al. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies. Bone Marrow Transplant 1993; 12: 253-259.
15. Villalün L, Avello AG, César J, Odriozola J, Lüpez J, Oteyza JP et al. Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)? Thromb Res 2000; 99: 439-446.
16. Tanikawa S, Mori S, Ohhashi K, Akiyama H, Sasaki T, Kaku H et al. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study. Bone Marrow Transplant 2000; 26: 881-886.
17. Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study. Blood 2000; 96: 2391-2398.
18. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
19. Peltonen S, Lassila R, Rossi P, Salenius JP, Lepäntalo M. Blood coagulation and fibrinolysis activation during sudden arterial occlusion of lower extremities-an association with ischemia and patient outcome. Thromb Haemost 1995; 74: 1442-1446.
20. Stephens R, Leung KC, Pö llänen J, Salonen EM, Vaheri A. Microplate immunocapture assay for plasminogen activators and their specific inhibitors. J Immunol Methods 1987; 105: 245-251.
21. Brandão LR, Kletzel M, Boulad F, Kurtzberg J, Maloney K, Fligman I et al. A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. Pediatr Blood Cancer 2008; 50: 1240-1246.
22. Heissig B, Lund LR, Akimyama H, Ohki M, Morita Y, Ramer J et al. The plasminogen fibrinolytic pathway is required for hematopoietic regeneration. Cell Stem Cell 2007; 1: 658-670.
23. Weber M, Krö ger N, Langer F, Hansen A, Zabelina T, Eifrig B et al. Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31: 817-822.
24. Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated Intravascular Coagulation. Thromb Haemost 1999; 82: 695-705.
25. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastro-intestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-4213.
26. Pihusch R, Hö hnberg B, Salat C, Pihusch M, Hiller E, Kolb HJ. Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation. Ann Hematol 2002; 81: 454-461. (Pubitemid 36067659)
27. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996; 87: 4651-4663.
28. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA et al. Activated platelets mediate inflammatory signalling by regulated interleukin 1b synthesis. J Cell Biol 2001; 154: 485-490.
29. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007; 66: 159-165.